IP Library Granted Patent US 9,345,821
Granted Patent B2
US 9,345,821 · App. 14/218,582 · Granted May 24, 2016

Reduced-pressure sources, systems, and methods employing a polymeric, porous, hydrophobic material

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,345,821
App. No.
14/218,582
Granted
May 24, 2016
Kind
B2
Abstract

Reduced-pressure sources, systems, and methods involve using a vacuum pump that is disposed within a sealed space to produce reduced pressure. The exhaust from the vacuum pump is exhausted from the sealed space through pores in an enclosure member that is made of a polymeric, porous, hydrophobic material. Other devices, systems, and methods are disclosed.

Claims (38)

1. A reduced-pressure source for treating a tissue site, the reduced-pressure source comprising:

a pump housing comprising walls forming a sealed space;

a vacuum pump disposed within the walls of the pump housing;

a reduced-pressure outlet fluidly coupled to the vacuum pump, and configured to provide reduced pressure generated by the vacuum pump to a reduced-pressure chamber disposed within the walls of the pump housing; and

an exhaust outlet: (i) disposed within and fluidly coupled to the sealed space; (ii) fluidly coupled to the vacuum pump; and (iii) configured to discharge a positive pressure exhaust gas generated by the vacuum pump into a positive-pressure chamber in the sealed space;

wherein a hydrophobic polymer forms a substantial portion of at least one wall of the walls of the pump housing and is configured so that the positive pressure exhaust gas exits the sealed space through the hydrophobic polymer and wherein the hydrophobic polymer is further configured to prevent liquid ingress into the sealed space from an exterior of the pump housing.

2. The reduced-pressure source of claim 1 , wherein the hydrophobic polymer comprises a sintered polymer.

3. The reduced-pressure source of claim 1 , wherein the hydrophobic polymer comprises spun-bonded fibers.

4. The reduced-pressure source of claim 1 , wherein the hydrophobic polymer is formed from hydrophobic fibers.

5. The reduced-pressure source of claim 1 , wherein the reduced-pressure chamber comprises a conduit fluidly coupled to the reduced-pressure outlet.

6. The reduced-pressure source of claim 1 , wherein the reduced-pressure chamber further comprises a conduit configured to deliver reduced pressure from the vacuum pump to a canister for receiving fluid from the tissue site.

7. The reduced-pressure source of claim 1 , wherein the hydrophobic polymer forms a panel of at least one wall of the pump housing.

8. A reduced-pressure source for treating a tissue site, the reduced-pressure source comprising:

an enclosure member having walls forming a sealed space and comprising therein a positive-pressure chamber, a reduced-pressure chamber, and a vacuum pump;

a reduced-pressure outlet fluidly coupled to the vacuum pump and configured to provide reduced pressure from the vacuum pump to the reduced-pressure chamber; and

an exhaust outlet: (i) disposed within the walls of the enclosure member; (ii) fluidly coupled to the sealed space and to the vacuum pump; and (iii) configured to discharge a positive pressure exhaust gas from the vacuum pump to the positive-pressure chamber;

wherein the enclosure member comprises a hydrophobic polymer forming a substantial portion of at least one wall of the walls and configured so that the positive pressure exhaust gas from the positive-pressure chamber exits the enclosure member through the hydrophobic polymer.

9. The reduced-pressure source of claim 8 , wherein the reduced-pressure chamber further comprises a conduit fluidly coupled to the reduced-pressure outlet.

10. The reduced-pressure source of claim 8 , wherein the hydrophobic polymer of the at least one wall of the walls of the enclosure member is configured to inhibit ingress of liquid into the sealed space from an exterior of the enclosure member.

11. The reduced-pressure source of claim 8 , wherein the hydrophobic polymer comprises a sintered polymer.

12. The reduced-pressure source of claim 8 , wherein the hydrophobic polymer comprises spun-bonded fibers.

13. The reduced-pressure source of claim 8 , wherein the hydrophobic polymer is formed from hydrophobic fibers.

14. The reduced-pressure source of claim 8 , further comprising a canister fluidly coupled to the reduced-pressure chamber.

15. The reduced-pressure source of claim 8 , wherein the hydrophobic polymer comprises micro-apertures of 1 micron or less.

16. An apparatus for providing reduced pressure to a tissue site, the apparatus comprising:

a vacuum pump disposed within an enclosure member having walls forming a sealed space, the walls of the enclosure member further enclosing therein a reduced-pressure chamber and a positive-pressure chamber;

a reduced-pressure outlet fluidly coupled to the vacuum pump and configured to provide reduced-pressure generated by the vacuum pump to the reduced-pressure chamber; and

an exhaust outlet: (i) disposed within the walls of the enclosure member; (ii) fluidly coupled to the sealed space and to the vacuum pump; and (iii) configured to discharge a positive pressure exhaust gas generated by the vacuum pump to the positive-pressure chamber;

the enclosure member comprising a hydrophobic polymer forming a substantial portion of at least one wall of the walls, the hydrophobic polymer configured to inhibit ingress of liquid to the vacuum pump from an exterior of the enclosure member and to allow the positive pressure exhaust gas to exit the enclosure member through the hydrophobic polymer.

17. The apparatus of claim 16 , further comprising a canister fluidly coupled to the reduced-pressure chamber.

18. The apparatus of claim 16 , further comprising:

a treatment manifold configured to distribute reduced pressure across the tissue site; and

a sealing member configured to cover the treatment manifold.

19. The apparatus of claim 16 , wherein the hydrophobic polymer is a sintered polymer.

20. The apparatus of claim 19 , further comprising:

a canister fluidly coupled to the reduced-pressure chamber;

a treatment manifold fluidly coupled to the canister; and

a sealing member configured to cover the treatment manifold.

Assignments (6)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 1, 2024
From: 3M INNOVATIVE PROPERTIES COMPANY
To: SOLVENTUM INTELLECTUAL PROPERTIES COMPANY
Reel/Frame 066430/0333 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 28, 2023
From: KCI LICENSING, INC.
To: 3M INNOVATIVE PROPERTIES COMPANY
Reel/Frame 064730/0218 →
RELEASE OF SECURITY INTEREST IN PATENTS Recorded Nov 7, 2019
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: KCI USA, INC.; KCI LICENSING, INC.
Reel/Frame 050966/0547 →
RELEASE OF SECURITY INTEREST REEL/FRAME 040098/0268 Recorded Feb 8, 2017
From: WILMINGTON TRUST
To: KCI USA, INC.
Reel/Frame 041666/0320 →
LIMITED THIRD LIEN INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Oct 7, 2016
From: KCI USA, INC.; LIFECELL CORPORATION; KCI LICENSING, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 040291/0237 →
SECOND LIEN SECURITY AGREEMENT Recorded Sep 21, 2016
From: KCI USA, INC.; LIFECELL CORPORATION; KCI LICENSING, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 040098/0268 →